Aggarwal, C., Redman, M. W., Lara, P. N., Borghaei, H., Hoffman, P., Bradley, J. D., . . . Gandara, D. R. (2019). Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). J Thorac Oncol.
Citación estilo ChicagoAggarwal, Charu, et al. "Brief Report: SWOG S1400D (), A Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 In Previously-treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)." J Thorac Oncol 2019.
Cita MLAAggarwal, Charu, et al. "Brief Report: SWOG S1400D (), A Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 In Previously-treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)." J Thorac Oncol 2019.